by Gary Finnegan: Ten medicines, including a first-in-class orphan medicine for narcolepsy, were recommended for authorisation in the EU at the latest meeting of the European Medicines Agency’s Committee for Medicinal… read more.
by Bruce Sylvester: Surgical resection is a safe and helpful treatment option for a broad range of patients with early-stage lung cancer, researchers reported online on Nov. 10,… read more.
by Gary Finnegan: The European Medicines Agency’s key committee approved a total of 19 new medicines at its meeting in late September – the highest number of products… read more.
Men with asthma are less likely to have aggressive prostate cancer or to die from the disease, according to a large, prospective cohort study published in the International… read more.
Firmagon (Degarelix) is a competitive, reversible GnRH receptor blocker, for patients with advanced hormone-dependent prostate cancer. Where Injection technique is critical; Nora Sullivan, a specialist nurse at Hibernian… read more.
by Gary Finnegan: The European Medicines Agency’s influential Committee for Medicinal Products for Human Use (CHMP) has given the green light for ten new medicines, as well as offering… read more.
by Bruce Sylvester: Rociletinib, an investigative therapy for treatment resistant EGFR-mutation driven lung tumors, shows activity against the most common resistance mutation, and it significantly improves clinical outcomes.
by Bruce Sylvester: Pembrolizumab (Keytruda®), an anti-PD-1 antibody immunotherapy has shown efficacy in one fourth of patients with recurrent or metastatic head and neck cancer, researchers reported on… read more.
by Bruce Sylvester: In a Phase III trial comparing standard docetaxel chemotherapy with immunotherapy nivolumab, researchers reported that subjects with squamous-non-small cell lung cancer treated with nivolumab lived… read more.
Psychologists are to improve online health information on lung cancer after research showed that family members are more likely to search online to encourage loved ones to seek… read more.
by Bruce Sylvester: Lung cancer patients whose tumors carry specific mutations in the BRAF gene appear to benefit from drugs used to treat melanoma, researchers from the retrospective… read more.
by Bruce Sylvester: Results of a retrospective study suggest that, among middle-aged to elderly smokers, men have a higher risk than women of developing osteoporosis and fractures of… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
